Optimal uses of pooled testing for COVID-19 incorporating imperfect test performance and pool dilution effect: An application to congregate settings in Los Angeles County

J Med Virol. 2021 Sep;93(9):5396-5404. doi: 10.1002/jmv.27054. Epub 2021 May 27.

Abstract

Introduction: Pooled testing is a potentially efficient alternative strategy for COVID-19 testing in congregate settings. We evaluated the utility and cost-savings of pooled testing based on imperfect test performance and potential dilution effect due to pooling and created a practical calculator for online use.

Methods: We developed a 2-stage pooled testing model accounting for dilution. The model was applied to hypothetical scenarios of 100 specimens collected during a one-week time-horizon cycle for varying levels of COVID-19 prevalence and test sensitivity and specificity, and to 338 skilled nursing facilities (SNFs) in Los Angeles County (Los Angeles) (data collected and analyzed in 2020).

Results: Optimal pool sizes ranged from 1 to 12 in instances where there is a least one case in the batch of specimens. 40% of Los Angeles SNFs had more than one case triggering a response-testing strategy. The median number (minimum; maximum) of tests performed per facility were 56 (14; 356) for a pool size of 4, 64 (13; 429) for a pool size of 10, and 52 (11; 352) for an optimal pool size strategy among response-testing facilities. The median costs of tests in response-testing facilities were $8250 ($1100; $46,100), $6000 ($1340; $37,700), $6820 ($1260; $43,540), and $5960 ($1100; $37,380) when adopting individual testing, a pooled testing strategy using pool sizes of 4, 10, and optimal pool size, respectively.

Conclusions: Pooled testing is an efficient strategy for congregate settings with a low prevalence of COVID-19. Dilution as a result of pooling can lead to erroneous false-negative results.

Keywords: COVID-19; congregate setting; cost saving; dilution; pooled testing; skilled nursing facilities.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19 / diagnosis*
  • COVID-19 / economics
  • COVID-19 / epidemiology*
  • COVID-19 / virology
  • COVID-19 Nucleic Acid Testing / economics
  • COVID-19 Nucleic Acid Testing / methods*
  • California / epidemiology
  • False Negative Reactions
  • Humans
  • Models, Statistical*
  • Nasopharynx / virology
  • Prevalence
  • RNA, Viral / genetics*
  • SARS-CoV-2 / genetics*
  • Sensitivity and Specificity
  • Skilled Nursing Facilities
  • Specimen Handling / economics
  • Specimen Handling / methods*

Substances

  • RNA, Viral